Cetera Advisor Networks’s Medifast MED Stock Holding History

Cetera Advisor Networks’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,163	Closed	-$250K	–	2645
2022 Q4	$250K	Buy	2,163 +300	+16%	+$34.9K	﹤0.01%	2115
2022 Q3	$202K	Sell	1,863 -1,964	-51%	-$281K	﹤0.01%	1858
2022 Q2	$691K	Buy	3,827 +750	+24%	+$134K	0.01%	1072
2022 Q1	$526K	Buy	3,077 +200	+7%	+$37.7K	0.01%	1266
2021 Q4	$603K	Buy	2,877 +732	+34%	+$151K	0.01%	1175
2021 Q3	$413K	Sell	2,145 -359	-14%	-$88.3K	0.01%	1326
2021 Q2	$709K	Buy	2,504 +110	+5%	+$29.8K	0.01%	984
2021 Q1	$507K	Buy	2,394 +830	+53%	+$199K	0.01%	867
2020 Q4	$307K	Buy	+1,564	New	+$276K	0.01%	1026
2020 Q3	–	Sell	-504	Closed	-$70K	–	2289
2020 Q2	$70K	Buy	+504	New	+$46.3K	﹤0.01%	1721
2018 Q4	–	Sell	-1,004	Closed	-$221K	–	1105
2018 Q3	$221K	Buy	+1,004	New	+$204K	0.01%	1002

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cetera Advisor Networks's MED Position: Q1 2023 in Review

Cetera Advisor Networks sold out of Medifast (MED) in Q1 2023, closing a stake of 2,163 shares — an estimated $250K sold.

Cetera Advisor Networks first reported a position in MED in Q3 2018 and held it in 11 quarters. The position peaked at $709K in Q2 2021. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

Cetera Advisor Networks reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
Cetera Advisor Networks sold 2,163 Medifast shares in Q1 2023, an estimated $250K.
Cetera Advisor Networks first reported a position in Medifast in Q3 2018 and held it in 11 quarters.
Cetera Advisor Networks's Medifast position peaked at $709K in Q2 2021.
267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on Cetera Advisor Networks's 13F filing for Q1 2023, filed 15 May 2023.